Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hsp27 as a therapeutic target in cancers.
Acunzo J, Andrieu C, Baylot V, So A, Rocchi P. Acunzo J, et al. Among authors: andrieu c. Curr Drug Targets. 2014 Apr;15(4):423-31. doi: 10.2174/13894501113146660230. Curr Drug Targets. 2014. PMID: 24138636 Review.
The hallmarks of castration-resistant prostate cancers.
Katsogiannou M, Ziouziou H, Karaki S, Andrieu C, Henry de Villeneuve M, Rocchi P. Katsogiannou M, et al. Among authors: andrieu c. Cancer Treat Rev. 2015 Jul;41(7):588-97. doi: 10.1016/j.ctrv.2015.05.003. Epub 2015 May 9. Cancer Treat Rev. 2015. PMID: 25981454 Review.
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P. Ziouziou H, et al. Among authors: andrieu c. Oncotarget. 2017 Aug 24;8(44):77317-77329. doi: 10.18632/oncotarget.20469. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100389 Free PMC article.
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P. Ziouziou H, et al. Among authors: andrieu c. Oncotarget. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683. eCollection 2018 Jun 19. Oncotarget. 2018. PMID: 29983898 Free PMC article.
Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer.
Ziouziou H, Paris C, Benizri S, Le TK, Andrieu C, Nguyen DT, Appavoo A, Taïeb D, Brunel F, Oueslati R, Siri O, Camplo M, Barthélémy P, Rocchi P. Ziouziou H, et al. Among authors: andrieu c. Pharmaceutics. 2021 Apr 27;13(5):623. doi: 10.3390/pharmaceutics13050623. Pharmaceutics. 2021. PMID: 33925528 Free PMC article.
The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.
Katsogiannou M, Andrieu C, Baylot V, Baudot A, Dusetti NJ, Gayet O, Finetti P, Garrido C, Birnbaum D, Bertucci F, Brun C, Rocchi P. Katsogiannou M, et al. Among authors: andrieu c. Mol Cell Proteomics. 2014 Dec;13(12):3585-601. doi: 10.1074/mcp.M114.041228. Epub 2014 Oct 2. Mol Cell Proteomics. 2014. PMID: 25277244 Free PMC article.
102 results